Co-encapsulation of human serum albumin and superparamagnetic iron oxide in PLGA nanoparticles: Part II. Effect of process variables on protein model drug encapsulation efficiency

Journal of Microencapsulation

Volumn 31, Issue 2, 2014, Pages 156-165

  Shubhra, Quazi T H ^a   Feczkó, Tivadar ^a,b   Kardos, Andrea F ^a,b   Tóth, Judit ^a,b   Mackova, Hana ^c   Horak, Daniel ^c   Dósa, György ^a   Gyenis, János ^a  

^a UNIVERSITY OF PANNONIA   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

Author keywords

Encapsulation efficiency; Experimental design; Human serum albumin; Magnetite nanoparticles; Poly(d,l lactic co glycolic) acid

Indexed keywords

DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; HUMANS; IMMOBILIZED PROTEINS; LACTIC ACID; MODELS, CHEMICAL; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; SERUM ALBUMIN;

EID: 84894221775     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2013.814730     Document Type: Article

References (41)

1. Allemann E, Leroux JC, Gurny R. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. Adv Drug Deliver Rev, 1998;34:171-89.
2. Andujar CB, Ortega D, Pankhurst QA, Thanh NTK. Elucidating the morphological and structural evolution of iron oxide nanoparticles formed by sodium carbonate in aqueous medium. J Mater Chem, 2012;22:12498-506.
3. Biro E, Nemeth AS, Feczko T, Toth J, Sisak C, Gyenis J. Three-step experimental design to determine the effect of process parameters on the size of chitosan microspheres. Chem Eng Process, 2009;48:771-9.
4. Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int J Pharm, 2007;336:367-75.
5. Burkersroda FV, Schedl L, Gopferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials, 2002;23:4221-31.
6. Coimbra PA, De Sousa HC, Gil MH. Preparation and characterization of flurbiprofen-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres. J Microencapsul, 2008;25:170-8.
7. Dey SK, Mandal B, Bhowmik M, Ghosh LK. Development and in vitro evaluation of Letrozole loaded biodegradable nanoparticles for breast cancer therapy. Braz J Pharm Sci, 2009;45:585-91.
8. Dillen K, Vandervoort J, Mooter GV, Ludwig A. Evaluation of ciprofloxacin-loaded Eudragit® RS100 or RL100/PLGA nanoparticles. Int J Pharm, 2006;314:72-82.
9. Feczko T, Toth J, Dosa G, Gyenis J. Influence of process conditions on the mean size of PLGA nanoparticles. Chem Eng Process, 2011a; 50:846-53.
10. Feczko T, Toth J, Dosa G, Gyenis J. Optimization of protein encapsulation in PLGA nanoparticles. Chem Eng Process, 2011b; 50:757-65.
11. Feczko T, Toth J, Gyenis J. Comparison of the preparation of PLGA-BSA nano- and microparticles by PVA, poloxamer and PVP Colloid Surface A, 2008;319:188-95.
12. Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (TaxolO) from nanospheres of biodegradable polymers. J Control Release, 2001;71:53-69.
13. Galindo-Rodriguez S, Allemann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res, 2004;21:1428-39.
14. Gorner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J Control Release, 1999;57:259-68.
15. Horak D, Semenyuk N, Lednicky F Effect of the reaction parameters on the particle size in the dispersion polymerization of 2-hydroxyethyl and glycidyl methacrylate in the presence of a ferrofluid. J Polym Sci A1, 2003;41:1848-63.
16. Ibrahim A, Couvreur P, Roland M, Speiser P. New magnetic drug carrier. J Pharm Pharmacol, 1983;35:59-61.
17. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glicolide) (PLGA) devices. Biomaterials, 2000;21:2475-90.
18. Jeon HJ, Jeong YL, Jang MK, Park YH, Nah JW. Effect of solvent on the preparation of surfactant-free poly (D, L-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. Int J Pharm, 2000;207:99-108.
19. Kusum VD, Bhosale UV. Formulation and optimization of polymeric nano drug delivery system of acyclovir using 3 full factorial design. Int J Pharm Tech Res, 2009;1:644-53.
20. Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: State of the art for process engineering approaches. Int J Pharm, 2008;363:26-39.
21. Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: Effect of formulation variables on size distribution. Int J Pharm, 2005;290:137-44.
22. Maravajhala V, Dasari N, Sepuri A, Joginapalli S. Design and evaluation of niacin microspheres. Indian J Pharm Sci, 2009;71:663-9.
23. Muller RH, Maassen S, Weyhers H, Mehnert W. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J Drug Target, 1996;4:161-70.
24. Nielsen SS. 2010. Food analysis part II, 4th edn. New York: Springer, p. 142.
25. Pamujula S, Graves RA, Kishore V, Mandal TK. Preparation and in vitro characterization of amifostine biodegradable microcapsules. Eur J Pharm Biopharm, 2004;57:213-18.
26. Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, Levy RJ, Labhasetwar V. Polymer degradation and in vitro release of a model protein from poly (D, L-lactide-co-glycolide) nano- and microparticles. J Control Release, 2003;92:173-87.
27. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliver Rev, 2003;55:329-47.
28. Park TG. Degradation of poly (lactide-co-glicolide acid) microspheres: Effect of copolymer composition. Biomaterials, 1995;16:1123-30.
29. Peppas LB. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm, 1995;116:1-9.
30. Sato H, Wang YM, Adachi I, Horikoshi I. Pharmacokinetics study of taxol-loaded poly (lactic-co-glycolic acid) microspheres containing isopropyl miristate after targeted delivery to the lung in mice. Biol Pharm Bull, 1996;19:1596-601.
31. Scholes PD, Coombes AGA, Illum L, Daviz SS, Vert M, Davies MC. The preparation of sub-200 nm poly (lactide-co-glycolide) microspheres for site-specific drug delivery. J Control Release, 1993;25:145-53.
32. Song X, Zhao Y, Wu W, Bi Y, Cai Z, Chen Q, Li Y, Hou S. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efficiency. Int J Pharm, 2008;350:320-9.
33. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release, 2001;70:1-20.
34. Ubrich N, Bouillot P, Pellerin C, Hoffman M, Maincent P. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study. J Control Release, 2004;97:291-300.
35. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev, 1999;11:3181-98.
36. Vert M, Schwach G, Engel R, Coudane J. Something new in the field of PLA/GA bioresorbable polymers? J Control Release, 1998;53:85-92.
37. Wang YM, Sato H, Adachi I, Horikoshi I. Preparation and characterization of poly (lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent. Taxol Chem Pharm Bull, 1996;44:1935-40.
38. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron oxide: Pharmacokinetics and toxicity. Am J Roentgenol, 1989;152:67-173.
39. Yang F, Bian C, Zhu L, Zhao G, Huang Z, Huang M. Effect of human serum albumin on drug metabolism: Structural evidence of esterase activity of human serum albumin. J Struct Biol, 2007;157:348-55.
40. Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso MJ, Labrude P, Vigneron C. Influence of experimental parameters on the characteristics of poly (lactic acid) nanoparticles prepared by a double emulsion method. J Control Release, 1998;50:31-40.
41. Zhao H, Gagnon J, Häfeli UO. Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres. Biomagn Res Technol, 2007;5:2.